Michael Shipton
Corporate Officer/Principal at SCIENCE 37 HOLDINGS, INC.
Profile
Michael Shipton's career history includes current and former positions as well as his education background.
Currently, he is the Chief Commercial Officer at Science 37 Holdings, Inc. Prior to this, he held the position of Senior VP-Customer Solutions & Strategy at Syneos Health, Inc. from 2021 to 2022.
Before that, he worked as the Senior Director & Global Head-Strategic Pricing at Quintiles Transnational Holdings, Inc. Mr. Shipton completed his undergraduate degree at North Carolina State University and obtained an MBA from Pfeiffer University.
Michael Shipton active positions
| Companies | Position | Start |
|---|---|---|
| SCIENCE 37 HOLDINGS, INC. | Corporate Officer/Principal | 2022-09-11 |
Former positions of Michael Shipton
| Companies | Position | End |
|---|---|---|
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 2021-12-31 |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Training of Michael Shipton
| North Carolina State University | Undergraduate Degree |
| Pfeiffer University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCIENCE 37 HOLDINGS, INC. | Commercial Services |
| Private companies | 2 |
|---|---|
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Quintiles Transnational Holdings, Inc.
Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Commercial Services |
- Stock Market
- Insiders
- Michael Shipton
